...
首页> 外文期刊>Drugs of the Future >Reducing attrition through early assessment of drug safety: Highlights from the Society of Medicines Research Symposium, held on March 13th, 2014 - National Heart & Lung Institute, Kensington, London, U.K
【24h】

Reducing attrition through early assessment of drug safety: Highlights from the Society of Medicines Research Symposium, held on March 13th, 2014 - National Heart & Lung Institute, Kensington, London, U.K

机译:通过对药物安全性的早期评估来减少人员流失:2014年3月13日举行的美国医学会研究专题讨论会的要点-英国伦敦肯辛顿国家心肺研究所

获取原文
获取原文并翻译 | 示例
           

摘要

The Society for Medicines Research Symposium, sponsored by Amsbio, Pfizer Neusentis and Takeda, was held at the National Heart and Lung Institute, Kensington, London, U.K. The meeting, organized by Wendy Alderton, Julie Holder, Ruth Lock and David Pryde, focused on reducing attrition through the early assessment of drug safety and brought together a range of international experts from both academia and industry to present the new technologies and their applications in early drug safety assessment.
机译:由Amsbio,Pfizer Neusentis和Takeda赞助的医学学会研究研讨会在英国伦敦肯辛顿的国家心脏和肺部研究所举行。由Wendy Alderton,Julie Holder,Ruth Lock和David Pryde组织的会议重点是通过对药物安全性的早期评估来减少人员流失,并汇集了来自学术界和工业界的一系列国际专家,以介绍新技术及其在早期药物安全性评估中的应用。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号